GNH USA

Europe — EMA

Metopirone

GNH USA supplies Metopirone (Metyrapone), a steroidogenesis inhibitor for diagnostic testing of adrenal insufficiency and treatment of Cushing's syndrome.

Metyrapone

Request sourcing

1
Pack/s

What is Metyrapone?

Metyrapone, the active ingredient in Metopirone, is a steroidogenesis inhibitor presented as a / for oral use. It is used in diagnostic testing for adrenal insufficiency and in the treatment of Cushing's syndrome.

GNH USA supplies Metopirone as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Metyrapone used for?

Metopirone acts on adrenal steroidogenesis and is employed in endocrine diagnostic and therapeutic protocols.

- Adrenal insufficiency (diagnostic testing): helps assess residual cortisol production capacity. - Cushing's syndrome (therapeutic): reduces cortisol synthesis to control hypercortisolism. - Endocrine research (experimental): used to investigate 11β‑hydroxylase function and steroid pathway dynamics.

What are the side effects of Metyrapone?

Metyrapone may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea - Dizziness - Headache - Fatigue

Serious or Rare Side Effects: - Adrenal crisis - Severe hypotension - Allergic reaction (rash, swelling, anaphylaxis)

What precautions apply to Metyrapone?

When using Metopirone, clinicians should consider several safety measures.

- Hepatic impairment: adjust dose or monitor liver function. - Electrolyte balance: monitor sodium and potassium levels regularly. - Abrupt discontinuation: taper to avoid adrenal insufficiency. - Pregnancy: evaluate risk‑benefit before prescribing. - Concomitant adrenal suppression: assess adrenal function before stopping therapy. - Store at ambient temperature: keep below 25°C, retain in original packaging, protect from moisture.

What does Metyrapone interact with?

Metyrapone can influence the activity of several co‑administered medicines.

Major Interactions (Avoid): - Ketoconazole: additive cortisol suppression may precipitate adrenal crisis. - Carbamazepine: induces metabolism, reducing metyrapone efficacy.

Moderate Interactions (Monitor Closely): - Warfarin: possible alteration of INR, require closer monitoring. - Oral contraceptives: may reduce hormonal effectiveness. - Antihypertensives: blood pressure response may change, adjust doses as needed.

Frequently asked questions

What is Metopirone used for?+
Metopirone (Metyrapone) is employed primarily for diagnostic testing of adrenal insufficiency and as a therapeutic option in Cushing's syndrome to lower excess cortisol production.
How does Metyrapone work?+
Metyrapone inhibits the adrenal enzyme 11β‑hydroxylase, blocking the final step of cortisol synthesis. This reduces cortisol levels while allowing precursor steroids to accumulate, which can be measured for diagnostic purposes or used therapeutically.
What is the usual dose of Metopirone?+
The specific dose of Metopirone is determined by the prescribing clinician based on the indication, patient characteristics, and laboratory monitoring. Dosage regimens are individualized and should follow the prescriber’s instructions.
Is Metopirone safe during pregnancy or breastfeeding?+
Safety data for Metyrapone in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any potential risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.
How do I order Metopirone from GNH USA?+
To order Metopirone, submit an enquiry on the product page at gnh-usa.com specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does Metopirone compare with other treatments for Cushing's syndrome?+
Metopirone is a steroidogenesis inhibitor that directly reduces cortisol synthesis, whereas other options such as ketoconazole, osilodrostat, or pituitary surgery target different steps or sources of excess cortisol. Choice of therapy depends on disease severity, comorbidities, and patient tolerance.
What are the storage and handling requirements for Metopirone?+
Metopirone should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture, and avoid exposure to direct sunlight or extreme heat.
How is Metopirone administered?+
Metopirone is administered orally. The tablet (or other oral formulation) is taken with water, and the exact timing and frequency are set by the prescribing clinician based on therapeutic goals and monitoring results.
What are the most serious risks associated with Metopirone?+
Serious risks include adrenal crisis, severe hypotension, and allergic reactions such as anaphylaxis. Patients should be monitored for signs of acute adrenal insufficiency and instructed to seek immediate medical attention if severe symptoms develop.
Who should not use Metopirone?+
Metopirone is contraindicated in patients with known hypersensitivity to Metyrapone or any excipients, and it should be used with caution in individuals with severe hepatic impairment, uncontrolled hypertension, or active adrenal insufficiency without appropriate monitoring.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Metyrapone
Route
Oral Use
Manufacturer
Esteve Pharmaceuticals, S.A.
Origin
EU

Related products